Analyst consensus rating
Abeona Therapeutics Analyst Rating: none
Direct answer
Abeona Therapeutics's consensus rating is none.
8 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $18.88.
Forecast evidence checked November 4, 2026.
Get free Abeona Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.25
- Average price target
- $18.88
- High price target
- $30.00
- Low price target
- $14.00
- Low target gap
- +229.4%
- Target upside
- +344.1%
- High target gap
- +605.9%
- Target range width
- 376.5%
- Consensus rating
- none
- Analysts
- 8
- Evidence date
- November 4, 2026
- Valid through
- November 11, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Abeona Therapeutics?
Abeona Therapeutics has a verified none consensus. The same dataset has an average price target of $18.88.
How far are Abeona Therapeutics's low and high targets from the recorded price?
The low target implies +229.4%, while the high target implies +605.9%.
How many analysts are included in Abeona Therapeutics's consensus?
The verified consensus includes 8 analysts.
How is Abeona Therapeutics's target upside or downside calculated?
The average target of $18.88 is divided by the recorded price of $4.25, then one is subtracted to produce +344.1%. This does not guarantee a future return.
When was Abeona Therapeutics's analyst forecast verified?
The data was verified on 2026-11-04. The dataset is valid through 2026-11-11.